F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, medical record review, staff interview, and facility policy, the facility failed to ensure
medications were administered by route ordered by the physician, which resulted in four medication errors
out of 28 opportunities for a medication administration error rate of 14.28 percent (%). This affected one
(#4) of three residents observed during medication administration. The facility census was 65.
Residents Affected - Few
Findings include:
Observation on 03/12/24 at 8:18 A.M. noted Licensed Practical Nurse (LPN) #200 obtaining Resident #4
medications from medication cart. Medications included Abilify 2 milligram (mg) tablet, Lexapro 5 mg tablet,
Metoprolol 25 mg tablet, Plavix 75 mg tablet. LPN #200 placed the tablets into a medication cup and
proceeded to Resident #4 room. LPN #200 then proceeded to place each tablet into Resident #4 mouth
followed by a drink of water. Once medications were consumed LPN #200 departed the room.
Review of Resident #4 medical record identified the following physician medication orders and associated
route of administration. On 02/21/24 Abilify 2 mg via Gastrostomy tube (G-Tube) given one time daily for
anxiety disorder. On 02/19/24 Lexapro 5 mg via G-Tube given one time daily for anxiety and depression. On
02/19/24 Metoprolol 25 mg give 100 mg via G-Tube one time daily for hypertension. On 02/21/24 Plavix 75
mg via G-Tube one time daily related to history of transient ischemic attack and cerebral infarction.
On 03/12/24 at 1:27 P.M. interview with LPN #200 during review of medical record confirmed Resident #4's
medications were ordered to be administered via G-Tube and not by mouth (PO).
Review of the medication administration policy revised 08/22/22 revealed staff should review the Medication
Administration Record (MAR) to identify medication to be administered. Compare medication source
(bubble pack, vial, etc.) with MAR to verify medication name, form, dose, route and time. Administer
medications as ordered. Sign MAR after administered. Report and document any adverse side effects of
refusals.
This deficiency represents non-compliance investigated under Complaint Number OH00151380.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
366073
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366073
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Embassy of Swanton
214 S Munson Rd
Swanton, OH 43558
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, staff interview, and facility policy, the facility failed to ensure medications were
obtained and administered as ordered by the physician resulting in significant medication errors. This
affected one (#13) of six sampled residents reviewed for medication administration. The facility census was
65.
Residents Affected - Few
Findings include:
Resident #13 readmitted from the hospital on [DATE] with the diagnosis including, chronic respiratory
failure, dependence on respirator, chronic obstructive pulmonary disease, gastrostomy tube, and
tracheostomy. According to the minimum data set assessment dated [DATE] Resident #13 was assessed
with moderately impaired cognition, dependent on staff for the completion of activities of daily living,
experienced constant pain with pain medication administration including opioid administration.
Review of Resident #13's physician orders noted the following medications ordered on 02/16/24; Metoprolol
Tartrate Tablet 25 milligrams (mg) give one tablet via gastrostomy tube (G-Tube) two times a day for
hypertension, MagOx 400 Oral Tablet give 400 mg via G-Tube two times a day for supplement, Seroquel
Oral Tablet give 50 mg via G-Tube one time a day for anxiety, Trazodone Oral Tablet 50 mg via G-Tube one
time a day for insomnia, Donepezil Oral Tablet give 10 mg via G-Tube one time a day for anxiety, Lasix Oral
Tablet give 20 mg via G-Tube one time a day for congestive heart failure, Apixaban Oral Tablet give 5 mg
via G-Tube two times a day for venous thromboembolism (VTE) prophylaxis, Lipitor Oral Tablet give 10 mg
via G-Tube one time a day for hyperlipidemia. On 02/21/24 Sertraline 50 mg via G-Tube once daily for major
depression was ordered.
Review of the medication administration record (MAR) from February 2024 noted the following medications
documented as being omitted and not given as ordered; Metoprolol Tartrate Tablet 25 milligrams (mg) MAR
scheduled to be given at bedtime omitted dose 02/18/24. MagOx 400 mg MAR scheduled to be given at
morning upon rising and at bedtime missed morning dose on 02/18/24 and bedtime dose on 02/22/24.
Seroquel 50 mg MAR scheduled to be given at bedtime missed doses on 02/17/24, 02/18/24, 02/19/24,
02/20/24. Trazodone 50 mg MAR scheduled to be given at bedtime missed doses on 02/18/24, 02/19/24,
02/20/24. Donepezil 10 mg MAR scheduled to be given at bedtime missed doses on 02/18/24, 02/19/24,
02/20/24. Lasix 20 mg MAR scheduled to be given at morning upon rising missed 02/19/24 dose. Apixaban
Oral Tablet 5 mg MAR scheduled to be given at morning upon rising and at bedtime missed bedtime doses
on 02/18/24, 02/20/24, 02/21/24 and missed morning doses on 02/21/24, 02/22/22. Lipitor Oral Tablet 10
mg MAR scheduled to be given at bedtime missed doses on 02/17/24, 02/18/24, 02/19/24, 02/20/24.
Sertraline 50 mg ordered on 02/21/24 MAR scheduled to be given in morning upon rising missed dose on
02/22/24. Further review of the medical record lacked documentation indicating the physician was notified
of the medications being omitted (missed) or a second pharmacy being contacted in an attempt to obtain
the medications.
On 03/13/24 at 8:55 A.M. interview with the Director of Nursing (DON) during a review of Resident #13's
medical record revealed the facility had difficulty obtaining certain medications for the resident on the listed
dates. The DON stated the pharmacy reported lack of supply leading to the medications not being
obtained. The DON further verified the physician was not notified of the medications not being obtained or
administered and lack of a secondary pharmacy being contacted in an attempt to obtain Resident #13
medications.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366073
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366073
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Embassy of Swanton
214 S Munson Rd
Swanton, OH 43558
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Review of the medication administration policy revised 08/22/22 revealed staff should review the Medication
Administration Record (MAR) to identify medication to be administered. Compare medication source
(bubble pack, vial, etc.) with MAR to verify medication name, form, dose, route and time. Administer
medications as ordered. Sign MAR after administered. Report and document any adverse side effects of
refusals.
Residents Affected - Few
Review of medication reordering policy dated revised 01/01/2024 revealed the facility will utilize a
systematic approach to provide or obtain routine and emergency medications and biological's in order to
meet the needs of each resident. Acquisition of medications should be completed in a timely manner to
ensure medications are administered in a timely manner. If a medication is not available to be administered
and not in the emergency kit the nurse will notify the pharmacy, physician, resident and or responsible
party.
This deficiency represents non-compliance investigated under Complaint Number OH00151380.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366073
If continuation sheet
Page 3 of 3